selenocysteine and Brain Neoplasms

selenocysteine has been researched along with Brain Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, MZ; Fan, CD; Fu, XT; Fu, XY; Shao, LR; Sun, BL; Sun, JY; Yang, MF; Yang, XY; Zhang, HF; Zhang, ZY; Zhao, SJ	1

Other Studies

1 other study(ies) available for selenocysteine and Brain Neoplasms

Article	Year
Selenocysteine induces apoptosis in human glioma cells: evidence for TrxR1-targeted inhibition and signaling crosstalk. Scientific reports, 2017, 07-25, Volume: 7, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; DNA Damage; Glioma; Humans; MAP Kinase Signaling System; Mice, Inbred BALB C; Mitochondria; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Selenocysteine; Signal Transduction; Thioredoxin Reductase 1; Xenograft Model Antitumor Assays	2017

Article

Year

Selenocysteine induces apoptosis in human glioma cells: evidence for TrxR1-targeted inhibition and signaling crosstalk.

Scientific reports, 2017, 07-25, Volume: 7, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; DNA Damage; Glioma; Humans; MAP Kinase Signaling System; Mice, Inbred BALB C; Mitochondria; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Selenocysteine; Signal Transduction; Thioredoxin Reductase 1; Xenograft Model Antitumor Assays

2017